AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD VM VUCHICH MJ COOLEY L LAUER SJ MAHONEY DH SHUSTER JJ PAYMENT C BERNSTEIN ML AKABUTU JJ BOWEN T KAMEN BA WATSON MS LOOK AT PULLEN DJ CAMITTA B
Citation: Vm. Whitehead et al., TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 183-188
TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD VM VUCHICH MJ COOLEY L LAUER SJ MAHONEY DH SHUSTER JJ PAYMENT C BERNSTEIN ML AKABUTU JJ BOWEN T KAMEN BA WATSON MS LOOK AT PULLEN DJ CAMITTA B
Citation: Vm. Whitehead et al., TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 183-188
INTENSIVE ALTERNATING DRUG PAIRS AFTER REMISSION INDUCTION FOR TREATMENT OF INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY
Authors: LAUER SJ CAMITTA BM LEVENTHAL BG MAHONEY D SHUSTER JJ KIEFER G PULLEN J STEUBER CP CARROLL AJ KAMEN B
Citation: Sj. Lauer et al., INTENSIVE ALTERNATING DRUG PAIRS AFTER REMISSION INDUCTION FOR TREATMENT OF INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY, Journal of pediatric hematology/oncology, 20(3), 1998, pp. 229-233
ACUTE NEUROTOXICITY IN CHILDREN WITH B-PRECURSOR ACUTE LYMPHOID LEUKEMIA - AN ASSOCIATION WITH INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND INTRATHECAL TRIPLE THERAPY - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MAHONEY DH SHUSTER JJ NITSCHKE R LAUER SJ STEUBER CP WINICK N CAMITTA B
Citation: Dh. Mahoney et al., ACUTE NEUROTOXICITY IN CHILDREN WITH B-PRECURSOR ACUTE LYMPHOID LEUKEMIA - AN ASSOCIATION WITH INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND INTRATHECAL TRIPLE THERAPY - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(5), 1998, pp. 1712-1722
INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE IS SUPERIOR TO REPETITIVE LOW-DOSE ORAL METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE FOR CHILDREN WITH LOWER-RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PHASE-III TRIAL
Authors: MAHONEY DH SHUSTER J NITSCHKE R LAUER SJ WINICK N STEUBER CP CAMITTA B
Citation: Dh. Mahoney et al., INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE IS SUPERIOR TO REPETITIVE LOW-DOSE ORAL METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE FOR CHILDREN WITH LOWER-RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PHASE-III TRIAL, Journal of clinical oncology, 16(1), 1998, pp. 246-254
E2A-PBX1 CHIMERIC TRANSCRIPT STATUS AT END OF CONSOLIDATION IS NOT PREDICTIVE OF TREATMENT OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH A T(1-19)(Q23-P13) - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: HUNGER SP FALL MZ CAMITTA BM CARROLL AJ LINK MP LAUER SJ MAHONEY DH PULLEN DJ SHUSTER JJ STEUBER CP CLEARY ML
Citation: Sp. Hunger et al., E2A-PBX1 CHIMERIC TRANSCRIPT STATUS AT END OF CONSOLIDATION IS NOT PREDICTIVE OF TREATMENT OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH A T(1-19)(Q23-P13) - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 91(3), 1998, pp. 1021-1028
ALTERED EXPRESSION OF P53 AND MDM-2 PROTEINS AT DIAGNOSIS IS ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: MARKS DI KURZ BW LINK MP NG E SHUSTER JJ LAUER SJ CARROLL D BRODSKY I HAINES DS
Citation: Di. Marks et al., ALTERED EXPRESSION OF P53 AND MDM-2 PROTEINS AT DIAGNOSIS IS ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(3), 1997, pp. 1158-1162
HYPERAMMONEMIC ENCEPHALOPATHY AFTER CHEMOTHERAPY - SURVIVAL AFTER TREATMENT WITH SODIUM BENZOATE AND SODIUM PHENYLACETATE
Authors: DELROSARIO M WERLIN SL LAUER SJ
Citation: M. Delrosario et al., HYPERAMMONEMIC ENCEPHALOPATHY AFTER CHEMOTHERAPY - SURVIVAL AFTER TREATMENT WITH SODIUM BENZOATE AND SODIUM PHENYLACETATE, Journal of clinical gastroenterology, 25(4), 1997, pp. 682-684
E2A-PBX1 CHIMERIC TRANSCRIPT STATUS AT END OF CONSOLIDATION IS NOT PREDICTIVE OF TREATMENT OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS (ALLS) WITH A T(1-19)(Q23-P13) - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY
Authors: HUNGER SP FALL MZ CAMITTA BM CARROLL AJ LINK MP LAUER SJ MAHONEY DH PULLEN DJ SHUSTER JJ STEUBER CP CLEARY ML
Citation: Sp. Hunger et al., E2A-PBX1 CHIMERIC TRANSCRIPT STATUS AT END OF CONSOLIDATION IS NOT PREDICTIVE OF TREATMENT OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS (ALLS) WITH A T(1-19)(Q23-P13) - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY, Blood, 90(10), 1997, pp. 1880-1880
PROGNOSTIC-SIGNIFICANCE OF FLUORESCENCE INTENSITY OF SURFACE MARKER EXPRESSION IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOROWITZ MJ SHUSTER J CARROLL AJ NASH M LOOK AT CAMITTA B MAHONEY D LAUER SJ PULLEN DJ
Citation: Mj. Borowitz et al., PROGNOSTIC-SIGNIFICANCE OF FLUORESCENCE INTENSITY OF SURFACE MARKER EXPRESSION IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 89(11), 1997, pp. 3960-3966
MDM-2 OVEREXPRESSION AND P53 GENE MUTATION AT DIAGNOSIS ARE ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: HAINES DS MARKS DI KURZ BI LINK MP NG E SHUSTER JJ LAUER SJ CARROLL D BRODSKY I
Citation: Ds. Haines et al., MDM-2 OVEREXPRESSION AND P53 GENE MUTATION AT DIAGNOSIS ARE ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 14(5), 1996, pp. 2018-2018
STAGE-I AND STAGE-II HODGKINS-DISEASE IN THE PEDIATRIC POPULATION - LONG-TERM FOLLOW-UP OF PATIENTS STAGED PREDOMINANTLY CLINICALLY
Authors: ROCK DB MURRAY KJ SCHULTZ CJ LAUER SJ WILSON JF
Citation: Db. Rock et al., STAGE-I AND STAGE-II HODGKINS-DISEASE IN THE PEDIATRIC POPULATION - LONG-TERM FOLLOW-UP OF PATIENTS STAGED PREDOMINANTLY CLINICALLY, American journal of clinical oncology, 19(2), 1996, pp. 174-178
HIGH-INCIDENCE OF POTENTIAL P53 INACTIVATION IN POOR OUTCOME CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT DIAGNOSIS
Authors: MARKS DI KURZ BW LINK MP NG E SHUSTER JJ LAUER SJ BRODSKY I HAINES DS
Citation: Di. Marks et al., HIGH-INCIDENCE OF POTENTIAL P53 INACTIVATION IN POOR OUTCOME CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT DIAGNOSIS, Blood, 87(3), 1996, pp. 1155-1161
REPETITIVE LOW-DOSE ORAL METHOTREXATE AND INTRAVENOUS MERCAPTOPURINE TREATMENT FOR PATIENTS WITH LOWER RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY
Authors: MAHONEY DH CAMITTA BM LEVENTHAL BG SHUSTER JJ CIVIN CJ GANICK DJ LAUER SJ STEUBER CP KAMEN BA
Citation: Dh. Mahoney et al., REPETITIVE LOW-DOSE ORAL METHOTREXATE AND INTRAVENOUS MERCAPTOPURINE TREATMENT FOR PATIENTS WITH LOWER RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY, Cancer, 75(10), 1995, pp. 2623-2631
PROGNOSTIC-SIGNIFICANCE OF ANTIGEN FLUORESCENCE INTENSITY (FI) IN B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - EARLY OUTCOME DATA FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: BOROWITZ MJ SHUSTER J CARROLL AJ LOOK AT CAMITTA B MAHONEY D LAUER SJ PULLEN DJ
Citation: Mj. Borowitz et al., PROGNOSTIC-SIGNIFICANCE OF ANTIGEN FLUORESCENCE INTENSITY (FI) IN B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - EARLY OUTCOME DATA FROM THE PEDIATRIC-ONCOLOGY-GROUP, Blood, 86(10), 1995, pp. 150-150
P53 INACTIVATION IN POOR OUTCOME ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AT DIAGNOSIS
Authors: HAINES DS KURZ BW LINK MP NG E SHUSTER JJ LAUER SJ BRODSKY I MARKS DI
Citation: Ds. Haines et al., P53 INACTIVATION IN POOR OUTCOME ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AT DIAGNOSIS, Blood, 86(10), 1995, pp. 2907-2907
INTENSIVE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE TREATMENT OF HIGHER-RISK NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: CAMITTA B MAHONEY D LEVENTHAL B LAUER SJ SHUSTER JJ ADAIR S CIVIN C MUNOZ L STEUBER P STROTHER D KAMEN BA
Citation: B. Camitta et al., INTENSIVE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE TREATMENT OF HIGHER-RISK NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(7), 1994, pp. 1383-1389
OVEREXPRESSION OF HEPATIC LIPASE IN TRANSGENIC RABBITS LEADS TO A MARKED REDUCTION OF PLASMA HIGH-DENSITY-LIPOPROTEINS AND INTERMEDIATE DENSITY LIPOPROTEINS
Authors: FAN JL WANG JJ BENSADOUN A LAUER SJ DANG Q MAHLEY RW TAYLOR JM
Citation: Jl. Fan et al., OVEREXPRESSION OF HEPATIC LIPASE IN TRANSGENIC RABBITS LEADS TO A MARKED REDUCTION OF PLASMA HIGH-DENSITY-LIPOPROTEINS AND INTERMEDIATE DENSITY LIPOPROTEINS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(18), 1994, pp. 8724-8728
OVEREXPRESSION OF HUMAN APOLIPOPROTEIN-C-III IN TRANSGENIC MICE RESULTS IN AN ACCUMULATION OF APOLIPOPROTEIN-B48 REMNANTS THAT IS CORRECTEDBY EXCESS APOLIPOPROTEIN-E
Authors: DESILVA HV LAUER SJ WANG JJ SIMONET WS WEISGRABER KH MAHLEY RW TAYLOR JM
Citation: Hv. Desilva et al., OVEREXPRESSION OF HUMAN APOLIPOPROTEIN-C-III IN TRANSGENIC MICE RESULTS IN AN ACCUMULATION OF APOLIPOPROTEIN-B48 REMNANTS THAT IS CORRECTEDBY EXCESS APOLIPOPROTEIN-E, The Journal of biological chemistry, 269(3), 1994, pp. 2324-2335
ENHANCED BINDING AND UPTAKE OF REMNANT LIPOPROTEINS BY HEPATIC LIPASE-SECRETING HEPATOMA-CELLS IN CULTURE
Authors: JI ZS LAUER SJ FAZIO S BENSADOUN A TAYLOR JM MAHLEY RW
Citation: Zs. Ji et al., ENHANCED BINDING AND UPTAKE OF REMNANT LIPOPROTEINS BY HEPATIC LIPASE-SECRETING HEPATOMA-CELLS IN CULTURE, The Journal of biological chemistry, 269(18), 1994, pp. 13429-13436
CORRECTION OF HEPATIC LIPASE DEFICIENCY IN TRANSGENIC RABBITS RESULTSIN A DRAMATIC REDUCTION OF HIGH-DENSITY-LIPOPROTEIN LEVELS IN PLASMA
Authors: FAN J WANG J LAUER SJ DANG Q SANAN DA BENSADOUN A MAHLEY RW TAYLOR JM
Citation: J. Fan et al., CORRECTION OF HEPATIC LIPASE DEFICIENCY IN TRANSGENIC RABBITS RESULTSIN A DRAMATIC REDUCTION OF HIGH-DENSITY-LIPOPROTEIN LEVELS IN PLASMA, Clinical research, 42(2), 1994, pp. 10000197-10000197
RECOMBINANT ALPHA-2B INTERFERON TREATMENT FOR CHILDHOOD T-LYMPHOBLASTIC DISEASE IN RELAPSE - A PEDIATRIC-ONCOLOGY-GROUP PHASE-II STUDY
Authors: LAUER SJ OCHS J POLLOCK BH BUCHANAN GR
Citation: Sj. Lauer et al., RECOMBINANT ALPHA-2B INTERFERON TREATMENT FOR CHILDHOOD T-LYMPHOBLASTIC DISEASE IN RELAPSE - A PEDIATRIC-ONCOLOGY-GROUP PHASE-II STUDY, Cancer, 74(1), 1994, pp. 197-202
ACCUMULATION OF METHOTREXATE POLYGLUTAMATES (MTXPGS) IN LYMPHOBLASTS,PLOIDY AND TRISOMY OF BOTH CHROMOSOME-4 CHROMOSOME-10 IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD VM VUCHICH MJ CARROLL AJ LAUER SJ MAHONEY D SHUSTER JJ PAYMENT C KOCH PA AKABUTU JJ BOWEN T KAMEN BA RAVINDRANATH Y EMAMI A BEARDSLEY GP PULLEN DJ CAMITTA B
Citation: Vm. Whitehead et al., ACCUMULATION OF METHOTREXATE POLYGLUTAMATES (MTXPGS) IN LYMPHOBLASTS,PLOIDY AND TRISOMY OF BOTH CHROMOSOME-4 CHROMOSOME-10 IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 84(10), 1994, pp. 10000515-10000515
APOA-IV IS SECRETED ON DISCRETE HDL PARTICLES BY THE RAT HEPATOMA-CELL LINE MCA-RH7777 TRANSFECTED WITH APOA-IV CDNA
Authors: YAO ZM LAUER SJ SANAN DA FAZIO S
Citation: Zm. Yao et al., APOA-IV IS SECRETED ON DISCRETE HDL PARTICLES BY THE RAT HEPATOMA-CELL LINE MCA-RH7777 TRANSFECTED WITH APOA-IV CDNA, Arteriosclerosis and thrombosis, 13(10), 1993, pp. 1476-1486
APOLIPOPROTEIN-E AND APOLIPOPROTEIN-C-III HAVE OPPOSING ROLES IN THE CLEARANCE OF LIPOPROTEIN REMNANTS IN TRANSGENIC MICE
Authors: DESILVA HV LAUER SJ MAHLEY RW WEISGRABER KH TAYLOR JM
Citation: Hv. Desilva et al., APOLIPOPROTEIN-E AND APOLIPOPROTEIN-C-III HAVE OPPOSING ROLES IN THE CLEARANCE OF LIPOPROTEIN REMNANTS IN TRANSGENIC MICE, Biochemical Society transactions, 21(2), 1993, pp. 483-487
Risultati: 1-25 | 26-27